Stay updated with breaking news from Report Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Rapidly advancing clinical pipeline across multiple high-value inflammatory, fibrotic and autoimmune diseasesOn track to launch a Phase 2a biomark...
– Announces successful completion of the Phase 1B portion of its Phase 1B/2 clinical trial Annamycin in combination with Cytarabine for the treatment of AML...
TORONTO, April 18, 2023 -- Galantas Gold Corporation is pleased to announce that drilling at the newly acquired Gairloch Project will commence in the coming weeks. Drill mobilization has... | April 18, 2023
TORONTO, Jan. 26, 2023 -- Galantas Gold Corporation is pleased to announce that it has entered into an agreement to acquire a 100% interest and the exclusive rights to explore and develop the... | January 26, 2023
Reunion Neuroscience Inc. Provides 2023 Corporate Update Company Plans to Report Phase 1 Interim Analysis for RE104 in Q1 2023 and Include Data Differentiating its Safety,... | January 4, 2023